ELEV – elevation oncology, inc. - common stock (US:NASDAQ)

News

Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements
Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2
Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com